Literature DB >> 33006724

Coffin-Siris syndrome and epilepsy.

Maria Rosaria Curcio1, Silvia Ferranti2, Federica Lotti3, Salvatore Grosso1,3.   

Abstract

Coffin-Siris syndrome is a rare genetic disorder defined by the presence of particular facial traits, congenital malformations, intellectual disability, and speech impairment. Epilepsy in Coffin-Siris syndrome has only occasionally been reported, and its features are poorly defined. We provide a detailed description of the clinical and instrumental findings of three patients with Coffin-Siris syndrome and epilepsy. The clinical diagnosis in our patients was confirmed by molecular analysis, which identified the presence of de novo mutations of ARID1B and SMARCB1 genes, in two patients and one patient, respectively. All the patients presented with epilepsy, with a mean age of seizure onset of 5.5 years. Seizures were brief and had a focal onset with secondary generalization. Electroencephalographic recording documented a unilateral, and less commonly bilateral, paroxysmal activity in the temporal, parietal, and occipital regions. Clinical response to anticonvulsive therapy was satisfactory, with a low rate of seizure recurrence. Our case series contributes to delineate the phenotype of Coffin-Siris syndrome. We wish this report could pave the way for further studies that will better define the prevalence and clinical manifestations of epilepsy in this rare syndrome.

Entities:  

Keywords:  ARID1B; Coffin-Siris; Epilepsy; SMARCB1; Seizures

Mesh:

Substances:

Year:  2020        PMID: 33006724     DOI: 10.1007/s10072-020-04782-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

1.  Cognitive and behavioral functioning in Coffin-Siris syndrome and epilepsy: a case presentation.

Authors:  H Allison Bender; Charles M Zaroff; Stella Karantzoulis; Luba Nakhutina; William S MacAllister; Daniel Luciano
Journal:  J Genet Psychol       Date:  2011 Jan-Mar       Impact factor: 1.509

2.  A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling.

Authors:  Dagmar Wieczorek; Nina Bögershausen; Filippo Beleggia; Sabine Steiner-Haldenstätt; Esther Pohl; Yun Li; Esther Milz; Marcel Martin; Holger Thiele; Janine Altmüller; Yasemin Alanay; Hülya Kayserili; Ludger Klein-Hitpass; Stefan Böhringer; Andreas Wollstein; Beate Albrecht; Koray Boduroglu; Almuth Caliebe; Krystyna Chrzanowska; Ozgur Cogulu; Francesca Cristofoli; Johanna Christina Czeschik; Koenraad Devriendt; Maria Teresa Dotti; Nursel Elcioglu; Blanca Gener; Timm O Goecke; Malgorzata Krajewska-Walasek; Encarnación Guillén-Navarro; Joussef Hayek; Gunnar Houge; Esra Kilic; Pelin Özlem Simsek-Kiper; Vanesa López-González; Alma Kuechler; Stanislas Lyonnet; Francesca Mari; Annabella Marozza; Michèle Mathieu Dramard; Barbara Mikat; Gilles Morin; Fanny Morice-Picard; Ferda Ozkinay; Anita Rauch; Alessandra Renieri; Sigrid Tinschert; G Eda Utine; Catheline Vilain; Rossella Vivarelli; Christiane Zweier; Peter Nürnberg; Sven Rahmann; Joris Vermeesch; Hermann-Josef Lüdecke; Michael Zeschnigk; Bernd Wollnik
Journal:  Hum Mol Genet       Date:  2013-08-01       Impact factor: 6.150

3.  Coffin-Siris and Nicolaides-Baraitser syndromes are a common well recognizable cause of intellectual disability.

Authors:  Francesca Mari; Annabella Marozza; Maria Antonietta Mencarelli; Caterina Lo Rizzo; Chiara Fallerini; Laura Dosa; Chiara Di Marco; Giulia Carignani; Margherita Baldassarri; Paola Cianci; Rossella Vivarelli; Marina Vascotto; Salvatore Grosso; Pietro Rubegni; Carla Caffarelli; Elena Pretegiani; Michele Fimiani; Livia Garavelli; Francesca Cristofoli; Joris R Vermeesch; Ranuccio Nuti; Maria Teresa Dotti; Paolo Balestri; Joussef Hayek; Angelo Selicorni; Alessandra Renieri
Journal:  Brain Dev       Date:  2014-09-22       Impact factor: 1.961

4.  The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome.

Authors:  Pleuntje J van der Sluijs; Sandra Jansen; Samantha A Vergano; Miho Adachi-Fukuda; Yasemin Alanay; Adila AlKindy; Anwar Baban; Allan Bayat; Stefanie Beck-Wödl; Katherine Berry; Emilia K Bijlsma; Levinus A Bok; Alwin F J Brouwer; Ineke van der Burgt; Philippe M Campeau; Natalie Canham; Krystyna Chrzanowska; Yoyo W Y Chu; Brain H Y Chung; Karin Dahan; Marjan De Rademaeker; Anne Destree; Tracy Dudding-Byth; Rachel Earl; Nursel Elcioglu; Ellen R Elias; Christina Fagerberg; Alice Gardham; Blanca Gener; Erica H Gerkes; Ute Grasshoff; Arie van Haeringen; Karin R Heitink; Johanna C Herkert; Nicolette S den Hollander; Denise Horn; David Hunt; Sarina G Kant; Mitsuhiro Kato; Hülya Kayserili; Rogier Kersseboom; Esra Kilic; Malgorzata Krajewska-Walasek; Kylin Lammers; Lone W Laulund; Damien Lederer; Melissa Lees; Vanesa López-González; Saskia Maas; Grazia M S Mancini; Carlo Marcelis; Francisco Martinez; Isabelle Maystadt; Marianne McGuire; Shane McKee; Sarju Mehta; Kay Metcalfe; Jeff Milunsky; Seiji Mizuno; John B Moeschler; Christian Netzer; Charlotte W Ockeloen; Barbara Oehl-Jaschkowitz; Nobuhiko Okamoto; Sharon N M Olminkhof; Carmen Orellana; Laurent Pasquier; Caroline Pottinger; Vera Riehmer; Stephen P Robertson; Maian Roifman; Caroline Rooryck; Fabienne G Ropers; Monica Rosello; Claudia A L Ruivenkamp; Mahmut S Sagiroglu; Suzanne C E H Sallevelt; Amparo Sanchis Calvo; Pelin O Simsek-Kiper; Gabriela Soares; Lucia Solaeche; Fatma Mujgan Sonmez; Miranda Splitt; Duco Steenbeek; Alexander P A Stegmann; Constance T R M Stumpel; Saori Tanabe; Eyyup Uctepe; G Eda Utine; Hermine E Veenstra-Knol; Sunita Venkateswaran; Catheline Vilain; Catherine Vincent-Delorme; Anneke T Vulto-van Silfhout; Patricia Wheeler; Golder N Wilson; Louise C Wilson; Bernd Wollnik; Tomoki Kosho; Dagmar Wieczorek; Evan Eichler; Rolph Pfundt; Bert B A de Vries; Jill Clayton-Smith; Gijs W E Santen
Journal:  Genet Med       Date:  2018-11-08       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.